In accordance with guidelines issued by the International Committee of Medical Journal Editors (ICJME), Diabetologia requires registration of clinical trials in a public trials registry. A clinical trial is defined as any research project that prospectively assigns people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioural treatments, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.
Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) do not require registration.
The ICMJE accepts registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (see http://www.who.int/ictrp/network/primary/en/index.html) or in ClinicalTrials.gov (www.clinicaltrials.gov).
The trial registry number should be included at the end of the Abstract.
Reports of randomised controlled trials (RCTs) should include the checklist items set out in the CONSORT guidelines. Authors must submit a completed CONSORT checklist. For reports of non-pharmacologic treatment interventions, please use the extension to the CONSORT statement.